Geoff Hale

Person

Oxford, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Modified immunoglobulin Fc regions
- Patent number 12,037,380
- Issue date Jul 16, 2024
- MABSOL VE LIMITED
- Geoffrey Hale
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods of tolerizing a primate to an antigen
- Patent number 7,947,272
- Issue date May 24, 2011
- Tolerx, Inc.
- Mark Frewin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD4 antibodies
- Patent number 7,541,443
- Issue date Jun 2, 2009
- Tolerrx, Inc.
- Mark Frewin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDW52-specific antibody for treatment of multiple sclerosis
- Patent number 6,120,766
- Issue date Sep 19, 2000
- Geoffrey Hale
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant CDw52 antigen
- Patent number 5,786,176
- Issue date Jul 28, 1998
- British Technology Group Limited
- Geoffrey Hale
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthetic CDw52(CAMPATH-1) peptide antigen
- Patent number 5,494,999
- Issue date Feb 27, 1996
- Geoffrey Hale
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CD36 ANTIBODIES AND THEIR USE TO TREAT CANCER
- Publication number 20250206836
- Publication date Jun 26, 2025
- ONA THERAPEUTICS S.L.
- Salvador AZNAR BENITAH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED IMMUNOGLOBULIN FC REGIONS
- Publication number 20250002561
- Publication date Jan 2, 2025
- Mabsolve Limited
- Geoffrey HALE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-CD36 ANTIBODIES AND THEIR USE TO TREAT CANCER
- Publication number 20230235073
- Publication date Jul 27, 2023
- ONA Therapeutics, S.L.
- Salvador AZNAR BENITAH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED IMMUNOGLUBIN FC REGIONS
- Publication number 20230235013
- Publication date Jul 27, 2023
- Mabsolve Limited
- Geoffrey HALE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compositions and methods of tolerizing a primate to an antigen
- Publication number 20110008330
- Publication date Jan 13, 2011
- Mark Frewin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods of tolerizing a primate to an antigen
- Publication number 20080160016
- Publication date Jul 3, 2008
- Mark Frewin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDw52-specific antibody for treatment of multiple sclerosis
- Publication number 20050118172
- Publication date Jun 2, 2005
- Geoffrey Hale
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of chronic joint inflammation
- Publication number 20050037004
- Publication date Feb 17, 2005
- Isis Innovation Limited
- John Isaacs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods of tolerizing a primate to an antigen
- Publication number 20030219403
- Publication date Nov 27, 2003
- Mark Frewin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRX1 antibody and uses therefor
- Publication number 20030108518
- Publication date Jun 12, 2003
- Mark Frewin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Modified immunoglobulin Fc regions

Compositions and methods of tolerizing a primate to an antigen

Anti-CD4 antibodies

CDW52-specific antibody for treatment of multiple sclerosis

Recombinant CDw52 antigen

Synthetic CDw52(CAMPATH-1) peptide antigen

Patents Applicationslast 30 patents

ANTI-CD36 ANTIBODIES AND THEIR USE TO TREAT CANCER

MODIFIED IMMUNOGLOBULIN FC REGIONS

ANTI-CD36 ANTIBODIES AND THEIR USE TO TREAT CANCER

MODIFIED IMMUNOGLUBIN FC REGIONS

Compositions and methods of tolerizing a primate to an antigen

Compositions and methods of tolerizing a primate to an antigen

CDw52-specific antibody for treatment of multiple sclerosis

Treatment of chronic joint inflammation

Compositions and methods of tolerizing a primate to an antigen

TRX1 antibody and uses therefor